Roxane Laboratories, Inc. v. Camber Pharmaceuticals Inc.

Opinion

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

ROXANE LABORATORIES, INC., Plaintiff-Appellant

v.

CAMBER PHARMACEUTICALS INC., INVAGEN PHARMACEUTICALS INC., Defendants-Appellees ______________________

2014-1803 ______________________

Appeal from the United States District Court for the District of New Jersey in No. 2:14-cv-04042-SRC-CLW, Judge Stanley R. Chesler. ______________________

JUDGMENT ______________________

KENNETH G. SCHULER, Latham & Watkins LLP, Chi- cago, IL, argued for plaintiff-appellant. Also represented by MARC NATHAN ZUBICK; ALEXANDER ENRICO LONG, San Diego, CA; GREGORY SOBOLSKI, San Francisco, CA; ROBERT J. GAJARSA, Washington, DC.

ROBERT S. SILVER, Caesar, Rivise, Bernstein, Cohen & Pokotilow, Ltd., Philadelphia, PA, argued for defendants- appellees. Also represented by JAMES J. KOZUCH, SALVATORE GUERRIERO, PEI-RU WEY. ______________________

THIS CAUSE having been heard and considered, it is

ORDERED and ADJUDGED:

PER CURIAM (LOURIE, REYNA, and CHEN, Circuit Judges). AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

March 12, 2015 /s/ Daniel E. O’Toole Date Daniel E. O’Toole Clerk of Court